06/29/2011 - GE Healthcare announced recently the availability of DaTscan™ (Ioflupane I 123 Injection), in more than 80 hospitals across the US. DaTscan is the first FDA-approved radiopharmaceutical adjunct imaging agent to help physicians evaluate patients with suspected parkinsonian syndromes, such as Parkinson's disease (PD).
05/11/2011 - Scientists studying alpha-synuclein, the protein involved in Lewy body dementia and Parkinson’s disease, have found that in its natural, healthy state the protein has a radically different structure than previously thought.
03/16/2011 - Do you know the difference between a CT scan, an MRI, or SPECT or PET scans? LBDA has put together a helpful overview on the different types of brain imaging and how they help differentiate between forms of dementia.
01/24/2011 - A recently published research paper by the European Journal of Neurology indicates that the presence of adult ADHD symptoms poses a 3-fold risk of developing DLB, but the LBDA Scientific Advisory Council has expressed concern that the conclusions drawn are premature.
10/08/2010 - ADNI GO, a landmark research study sponsored by the National Institute on Aging (NIA) at the National Institutes of Health (NIH), is examining the sequence and timing of events at the initial onset of mild cognitive symptoms.